153 related articles for article (PubMed ID: 27793944)
1. Imatinib-induced Gastrointestinal Vascular Ectasia in a Patient with Advanced GIST: Case Report and Literature Review.
Abu-Amna M; Awadie H; Bar-Sela G
Anticancer Res; 2016 Nov; 36(11):6151-6154. PubMed ID: 27793944
[TBL] [Abstract][Full Text] [Related]
2. Imatinib-induced gastric antral vascular ectasia in three patients with chronic myeloid leukaemia.
Ong J; Yeung D; Filshie R; Hughes TP; Nandurkar H
Int J Hematol; 2015 Nov; 102(5):639-42. PubMed ID: 26134364
[TBL] [Abstract][Full Text] [Related]
3. Gastric antral vascular ectasia in a patient with GIST after treatment with imatinib: case report and literature review.
Saad Aldin E; Mourad F; Tfayli A
Jpn J Clin Oncol; 2012 May; 42(5):447-50. PubMed ID: 22422898
[TBL] [Abstract][Full Text] [Related]
4. Resolution of gastric antral vascular ectasia following cessation of imatinib.
Maye JA; Baker O; Sheikh N
BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38388203
[TBL] [Abstract][Full Text] [Related]
5. Gastric Antral Vascular Ectasia during the Treatment of Chronic Myelogenous Leukemia with Imatinib Mesylate.
Narukawa K; Kakihana K; Fujiwara T; Kobayashi T; Doki N; Sakamaki H; Ohashi K
Intern Med; 2016; 55(1):69-72. PubMed ID: 26726089
[TBL] [Abstract][Full Text] [Related]
6. "Imatinib-induced gastric antral vascular ectasia" in a reporting system of the Japanese Adverse Drug Event Report database.
Oshima Y; Yuji K; Tojo A
Int J Hematol; 2016 May; 103(5):596-8. PubMed ID: 26980219
[No Abstract] [Full Text] [Related]
7. [Watermelon stomach: Chronic renal failure and/or imatinib?].
Montagnac R; Blaison D; Brahimi S; Schendel A; Levasseur T; Takin R
Nephrol Ther; 2015 Nov; 11(6):496-501. PubMed ID: 26165799
[TBL] [Abstract][Full Text] [Related]
8. [Imatinib mesylate (glivec) as a treatment for gastrointestinal stromal tumor (GIST)--long term follow-up].
Raccah E; Merimsky O; Kuten A; Apter S; Catane R
Harefuah; 2007 May; 146(5):329-34, 408. PubMed ID: 17674545
[TBL] [Abstract][Full Text] [Related]
9. Imatinib-induced agranulocytosis in patients with gastrointestinal stromal tumors.
Farag S; Verschoor AJ; Bosma JW; Gelderblom H; Kerst JM; Sleijfer S; Steeghs N
J Clin Pharmacol; 2015 Aug; 55(8):920-5. PubMed ID: 25810235
[TBL] [Abstract][Full Text] [Related]
10. Giant gastric gastrointestinal stromal tumor with severe peritoneal dissemination controlled by imatinib therapy following debulking surgery: a case report.
Fukuda S; Fujiwara Y; Wakasa T; Kitani K; Tsujie M; Yukawa M; Ohta Y; Inoue M
J Med Case Rep; 2017 Feb; 11(1):33. PubMed ID: 28166823
[TBL] [Abstract][Full Text] [Related]
11. Subdural hematoma in a patient taking imatinib for GIST: a case report and discussion of risk with other chemotherapeutics.
Theodotou CB; Shah AH; Ivan ME; Komotar RJ
Anticancer Drugs; 2016 Mar; 27(3):259-63. PubMed ID: 26628484
[TBL] [Abstract][Full Text] [Related]
12. [18F-FDG PET/CT in response evaluation of gastrointestinal stromal tumours treated with imatinib].
Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla JF; Sainz-Esteban A; Barragán J; Portilla-Quattrociocchi H; Carril JM
Rev Esp Med Nucl; 2008; 27(3):168-75. PubMed ID: 18570858
[TBL] [Abstract][Full Text] [Related]
13. S0502: A SWOG Phase III Randomized Study of Imatinib, With or Without Bevacizumab, in Patients With Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors.
Blanke CD; Rankin C; Corless C; Eary JF; Mulder K; Okuno SH; George S; Heinrich M
Oncologist; 2015 Dec; 20(12):1353-4. PubMed ID: 26576593
[TBL] [Abstract][Full Text] [Related]
14. Synchronous Large Gastrointestinal Stromal Tumor and Adenocarcinoma in the Stomach Treated with Imatinib Mesylate Followed by Total Gastrectomy.
Namikawa T; Munekage E; Munekage M; Maeda M; Yatabe T; Kitagawa H; Sakamoto K; Obatake M; Kobayashi M; Hanazaki K
Anticancer Res; 2016 Apr; 36(4):1855-9. PubMed ID: 27069170
[TBL] [Abstract][Full Text] [Related]
15. Very early detection of response to imatinib mesylate therapy of gastrointestinal stromal tumours using 18fluoro-deoxyglucose-positron emission tomography.
Heinicke T; Wardelmann E; Sauerbruch T; Tschampa HJ; Glasmacher A; Palmedo H
Anticancer Res; 2005; 25(6C):4591-4. PubMed ID: 16334147
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant imatinib in a locally advanced gastrointestinal stromal tumour (GIST) of the rectum: a rare case of two GISTs within a family without a familial GIST syndrome.
Mandalà M; Pezzica E; Tamborini E; Guerra U; Lagonigro SM; Forloni B; Barni S
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):711-3. PubMed ID: 17625442
[TBL] [Abstract][Full Text] [Related]
17. A safety evaluation of imatinib mesylate in the treatment of gastrointestinal stromal tumor.
Ben Ami E; Demetri GD
Expert Opin Drug Saf; 2016; 15(4):571-8. PubMed ID: 26865352
[TBL] [Abstract][Full Text] [Related]
18. Sigmoid Sinus Thrombosis Followed by Splenic Infarction Due to Imatinib Therapy in a Patient with Gastrointestinal Stromal Tumor; Hematological Side Effects of Imatinib.
Yilmaz H; Demirağ G; Yılmaz A
J Pharm Pharm Sci; 2021; 24():148-152. PubMed ID: 33784493
[TBL] [Abstract][Full Text] [Related]
19. PET/CT imaging of gastrointestinal stromal tumor with calcified peritoneal implants after imatinib therapy.
Eslamy HK; Quon A
Clin Nucl Med; 2008 Dec; 33(12):864-5. PubMed ID: 19033789
[TBL] [Abstract][Full Text] [Related]
20. Early onset imatinib mesylate-induced hepatotoxicity in a patient with gastrointestinal stromal tumors.
Yachoui R
Am J Ther; 2014; 21(5):e148-50. PubMed ID: 23567788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
